Clinical trial
Pregnancy Exposure Registry for Avonex (Interferon Beta-1a)
NCT00168714 · Biogen, Industry · Completed
Key facts
| NCT number | NCT00168714 |
|---|---|
| Title | Pregnancy Exposure Registry for Avonex (Interferon Beta-1a) |
| Official title | Avonex Pregnancy Exposure Registry |
| Lead sponsor | Biogen, Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Prenatal Exposure Delayed Effects, Multiple Sclerosis, Pregnancy |
| Intervention type | Drug |
| Interventions | BG9418 (interferon beta-1a) |
| Enrollment | 329 |
| Start date | Feb 1, 2004 |
| Primary completion | Sep 1, 2011 |
| Completion | Sep 1, 2011 |
| First posted | Sep 15, 2005 |
| Last update posted | Jun 9, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: